Aug 9 (Reuters)-
RaQualia Pharma Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2019 Jun 30, 2018 Dec 31, 2019
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 545 mln 445 mln 2.02
(+22.4 pct) (-3.8 pct) (+171.6 pct)
Operating loss 302 mln loss 558 mln 187 mln
Recurring loss 307 mln loss 569 mln 195 mln
Net loss 310 mln loss 596 mln 153 mln
EPS loss 15.19 yen loss 29.32 yen 7.52 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - RaQualia Pharma Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T